Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates

被引:134
作者
Gersin, Keith S. [1 ]
Rothstein, Richard I. [2 ]
Rosenthal, Raul J. [3 ]
Stefanidis, Dimitrios
Deal, Stephen E. [4 ]
Kuwada, Timothy S.
Laycock, William [2 ]
Adrales, Gina [2 ]
Vassiliou, Melina [2 ]
Szomstein, Samuel [3 ]
Heller, Stephen [5 ]
Joyce, Anne Marie [5 ]
Heiss, Frederick [5 ]
Neponmayshy, Dmitry [5 ]
机构
[1] Carolinas Med Ctr, Dept Surg, Charlotte, NC 28203 USA
[2] Dartmouth Hitchcock Med Ctr, Hanover, NH USA
[3] Cleveland Clin Florida, Weston, FL USA
[4] Carolina Digest Hlth Associates, Charlotte, NC USA
[5] Lahey Clin Med Ctr, Burlington, MA 01803 USA
关键词
GASTRIC BYPASS; INTRAGASTRIC BALLOON; OVERWEIGHT; IMPACT; RISK;
D O I
10.1016/j.gie.2009.11.051
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Background: The duodenojejunal bypass liner (DJBL) (Endo Barrier Gastrointestinal Liner) is an endoscopically placed and removable intestinal liner that creates a duodenojejunal bypass resulting in weight loss and improvement in type 2 diabetes mellitus. Objective: Weight loss before bariatric surgery to decrease perioperative complications. Design: Prospective, randomized, sham-controlled trial. Setting: Multicenter, tertiary care, teaching hospitals. Patients: Twenty-one obese subjects in the DJBL arm and 26 obese subjects in the sham arm composed the intent-to-treat population. Interventions: The subjects in the sham arm underwent an EGD and mock implantation. Both groups received identical nutritional counseling. Main Outcome Measurements: The primary endpoint was the difference in the percentage of excess weight loss (EWL) at week 12 between the 2 groups. Secondary endpoints were the percentage of subjects achieving 10% EWL, total weight change, and device safety. Results: Thirteen DJBL arm subjects and 24 sham arm subjects completed the 12-week study. EWL was 11.9% +/- 1.4% and 2.7% +/- 2.0% for the DJBL and sham arms, respectively (P < .05). In the DJBL arm, 62% achieved 10% or more EWL compared with 17% of the subjects in the sham arm (P < .05). Total weight change in the DJBL arm was -8.2 +/- 1.3 kg compared with -2.1 +/- 1.1 kg in the sham arm (P < .05). Eight DJBL subjects terminated early because of GI bleeding (n = 3), abdominal pain (n = 2), nausea and vomiting (n = 2), and an unrelated preexisting illness (n = 1). None had further clinical symptoms after DJBL explantation. Limitations: Study personnel were not blinded. There was a lack of data on caloric intake. Conclusions: The WE achieved endoscopic duodenal exclusion and promoted significant weight loss beyond a minimal sham effect in candidates for bariatric surgery. (Clinical trial registration number: NPT00469391.) (Gastrointest Endosc 2010;71:976-82.)
引用
收藏
页码:976 / 982
页数:7
相关论文
共 23 条
[1]
Is there a benefit to preoperative weight loss in gastric bypass patients? A prospective randomized trial [J].
Alami, Ramzi S. ;
Morton, John M. ;
Schuster, Rob ;
Lie, Jie ;
Sanchez, Barry R. ;
Peters, Anna ;
Curet, Myriam J. .
SURGERY FOR OBESITY AND RELATED DISEASES, 2007, 3 (02) :141-145
[2]
Preoperative weight loss as a predictor of long-term success following Roux-en-Y gastric bypass [J].
Alger-Mayer, Sharon ;
Polimeni, John M. ;
Malone, Margaret .
OBESITY SURGERY, 2008, 18 (07) :772-775
[3]
The impact of preoperative weight loss in patients undergoing Laparoscopic Roux-en-Y gastric bypass [J].
Alvarado, R ;
Alami, RS ;
Hsu, G ;
Safadi, BY ;
Sanchez, BR ;
Morton, JM ;
Curet, MJ .
OBESITY SURGERY, 2005, 15 (09) :1282-1286
[4]
[Anonymous], 1998, NIH PUBL
[5]
Wallstent and unusual gastrointestinal bleeding [J].
Balkan, M ;
Kozak, O ;
Arslan, I ;
Alpasian, F .
ENDOSCOPY, 2002, 34 (05) :431-431
[6]
Bariatric surgery: A systematic review and meta-analysis [J].
Buchwald, H ;
Avidor, Y ;
Braunwald, E ;
Jensen, MD ;
Pories, W ;
Fahrbach, K ;
Schoelles, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (14) :1724-1737
[7]
Surgical treatment of obesity [J].
Bult, Marielle J. F. ;
van Dalen, Thijs ;
Muller, Alex F. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 158 (02) :135-145
[8]
Evidence-based Review of the Bioenterics Intragastric Balloon for Weight Loss [J].
Dumonceau, Jean-Marc .
OBESITY SURGERY, 2008, 18 (12) :1611-1617
[9]
Impact of overweight on the risk of developing common chronic diseases during a 10-year period [J].
Field, AE ;
Coakley, EH ;
Spadano, JL ;
Laird, N ;
Dietz, WH ;
Rimm, E ;
Colditz, GA .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (13) :1581-1586
[10]
Duodenal-jejunal bypass sleeve: A totally endoscopic device for the treatment of morbid obesity [J].
Gersin, Keith S. ;
Keller, Jennifer E. ;
Stefanidis, Dimitrios ;
Simms, Connie S. ;
Abraham, Delois D. ;
Deal, Stephen E. ;
Kuwada, Timothy S. ;
Heniford, B. Todd .
SURGICAL INNOVATION, 2007, 14 (04) :275-278